Human IL-2 Instant ELISA

Description: The human IL-2 Instant ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human Interleukin-2. The human IL-2 Instant ELISA is for research use only. Not for diagnostic or therapeutic procedures.

IL-2 plays a central role in the activation and proliferation of lymphocytes that have been primed by antigens. IL-2 plays a pivotal role in for the expansion of most T-cells, natural killer cells and B-cells during certain phases of their response. IL-2 is a 15 kDa glycoprotein encoded by a single gene located in the q26-28 region of human chromosome 4. The cDNA deduced polypeptide consists of 153 amino acids. Apart from its most important role to mediate antigen-specific T-lymphocyte proliferation, IL-2 modulates the expression of interferon gamma and major histocompatibility antigens, stimulates proliferation and differentiation of activated B-cells, augments natural killer cell activity and inhibits granulocyte-macrophage colony formation. IL-2 displays antitumoral effects, thus being used in cancer therapy. Monitoring of IL-2 levels in serum provides more detailed insights in several pathological situations such as cancer, infectious diseases, transplant rejection, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and type I diabetes.

Citations: Drabko,Katarzyna; Bojarska-Junak,Agnieszka; Kowalczyk,Jerzy R.. Oxidative Status and Its Contribution to Extracellular Cytokine Secretion in Children with Acute Lymphoblastic Leukemia. Blood (ASH Annual Meeting Abstracts) 2006;108:4471(Link)

Paccani,Silvia Rossi; Tonello,Fiorella; Ghittoni,Raffaella; Natale,Mariarita; Muraro,Lucia; D'Elios,Mario Milco; Tang,Wei Jen; Montecucco,Cesare; Baldari,Cosima T.. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. Journal of Experimental Medicine 2005;201:325-331. (Link)

Falk,Markus; Ussat,Sandra; Reiling,Norbert; Wesch,Daniela; Kabelitz,Dieter; Adam-Klages,Sabine. Caspase Inhibition Blocks Human T Cell Proliferation by Suppressing Appropriate Regulation of IL-2, CD25, and Cell Cycle-Associated Proteins. The Journal of Immunology 2004;173:5077-5085. (Link)

Gunaydin,Serdar; Ayrancioglu,Kamil; Dikmen,Erkan; McCusker,Kevin; Vijay,Venkataramana; Sari,Tamer; Tezcaner,Tevfik; Zorlutuna,Yaman. Clinical effects of leukofiltration and surface modification on post-cardiopulmonary bypass atrial fibrillation in different risk cohorts. Perfusion 2007;22:279-288. (Link)

Lacomba,Manuel Santos; Martin,Carmen Marcos; Chamond,Rafael Ramirez; Galera,Jose Maria Gallardo; Omar,Mohamed; Estevez,Eduardo Collantes. Aqueous and Serum Interferon {gamma}, Interleukin (IL) 2, IL-4, and IL-10 in Patients With Uveitis. Archives of Ophthalmology 2000;118:768-772. (Link)

ALLENDE; CORELL; MANZANARES; MADRUGA; MARCOS; MADRONO; LOPEZ,G.O.Y.A.; GARCIA,P.E.R.E.; MORENO; RODRIGO; SANZ; ARNAIZ,V.I.L.L.. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology 1998;94:543-551. (Link)

Gunaydin,Serdar; McCusker,Kevin; Vijay,Venkataramana; Isbir,Selim; Sari,Tamer; Onur,Mehmet Ali; Gurpinar,Aylin; Sezgin,Aysun; Sargon,Mustafa F.; Tezcaner,Tevfik; Zorlutuna,Yaman. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts. Perfusion 2006;21:329-342. (Link)

Gobert,Michael; Treilleux,Isabelle; Bendriss-Vermare,Nathalie; Bachelot,Thomas; Goddard-Leon,Sophie; Arfi,Vanessa; Biota,Cathy; Doffin,Anne Claire; Durand,Isabelle; Olive,Daniel; Perez,Solene; Pasqual,Nicolas; Faure,Christelle; Ray-Coquard,Isabelle; Puisieux,Alain; Caux,Christophe; Blay,Jean Yves; Menetrier-Caux,Christine. Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome. Cancer Research 2009;69:2000-2009. (Link)

Pacheco-Castro,Alberto; Alvarez-Zapata,David; Serrano-Torres,Pilar; Regueiro,Jose R.. Signaling Through a CD3{gamma}-Deficient TCR/CD3 Complex in Immortalized Mature CD4+ and CD8+ T Lymphocytes. The Journal of Immunology 1998;161:3152-3160. (Link)

References: Naldini,A.; Fleischmann,W.R.,Jr.; Ballas,Z.K.; Klimpel,K.D.; Klimpel,G.R.. Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation. J.Immunol. 1987;139:1880-1884. (Link)

Tigges,M.A.; Casey,L.S.; Koshland,M.E.. Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway. Science 1989;243:781-786. (Link)

Gressler,V.H.; Weinkauff,R.E.; Franklin,W.A.; Golomb,H.M.. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2. Blood 1988;72:1048-1053. (Link)

Phadke,K.; Carlson,D.G.; Gitter,B.D.; Butler,L.D.. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models. J.Immunol. 1986;136:4085-4091. (Link)

Cornaby,A.; Simpson,M.; Vann,Rice R.; Dempsey,R.; Madras,P.; Jenkins,R.; Monaco,A.. Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients. Transplant Proc. 1988;20:827-830. (Link)